{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T05:10:19Z","timestamp":1698383419173},"reference-count":12,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,11,14]],"date-time":"2006-11-14T00:00:00Z","timestamp":1163462400000},"content-version":"vor","delay-in-days":5065,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Clinical Apheresis"],"published-print":{"date-parts":[[1993,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This is a review of therapeutic plasma products viz., coagulation factor concentrates, immunoglobulins, volume expanders, and protease inhibitors, and the progress made in rendering them free from transmitting infectious virus. Problems associated with the development of plasma products and the risks associated with their use are addressed. The recent technical advances designed to inactivate the hepatitis virus which led to the inactivation of HIV while preserving most of the biologic activity are reviewed. Today manufactured plasma products are essentially free from transmitting viral diseases of any significant clinical consequences. \u00a9 1993 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/jca.2920080213","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T16:15:35Z","timestamp":1172074535000},"page":"126-130","source":"Crossref","is-referenced-by-count":2,"title":["HIV inactivation in plasma products"],"prefix":"10.1002","volume":"8","author":[{"given":"Milton M.","family":"Mozen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,11,14]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1985.25686071422.x"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","unstructured":"Study Group of the UK Haemophilia Centre: Effect of dry heating of coagulation factor concentrates at 80\u00b0C for 72 hours on transmission of non\u2010A non\u2010B hepatitis.Lancet814\u2013816 1988.","DOI":"10.1016\/S0140-6736(88)92782-1"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1989.tb01144.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","unstructured":"LevyJA MitraG MozenMM: Recovery and inactivation of infectious retroviruses added to factor VIII concentrates.Lancet722\u2013723 1984.","DOI":"10.1016\/S0140-6736(84)92627-8"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6189183"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6200935"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6206563"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)91888-4"},{"key":"e_1_2_1_10_2","first-page":"1247","article-title":"HIV transmission to patients with hemophilia by heat treated, donor screened factor concentrate","volume":"142","author":"Remis RS","year":"1990","journal-title":"Can Med Assoc J"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood.V76.8.1593.1593","article-title":"Characterization of recombinant factor VIII and a recombinant factor VIII deletion mutant using a rabbit immunogenicity model system","volume":"76","author":"Esmon PC","year":"1990","journal-title":"Blood"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1986.26286152919.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1986.26486262753.x"}],"container-title":["Journal of Clinical Apheresis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjca.2920080213","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jca.2920080213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T07:24:50Z","timestamp":1698305090000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jca.2920080213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1993,1]]}},"alternative-id":["10.1002\/jca.2920080213"],"URL":"https:\/\/doi.org\/10.1002\/jca.2920080213","archive":["Portico"],"relation":{},"ISSN":["0733-2459","1098-1101"],"issn-type":[{"value":"0733-2459","type":"print"},{"value":"1098-1101","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1]]}}}